Department of Pharmaceuticals Denies Abbott’s Appeal Against BP Drug Metoprolol Pricing
The Pharmaceuticals Department (DoP) has turned down Abbott Healthcare’s appeal against the pricing cap set by the National Pharmaceutical Pricing Authority (NPPA) for high blood pressure medication metoprolol in its modified release tablet form. This decision follows multiple denials by […]
Department of Pharmaceuticals Denies Abbott’s Appeal Against BP Drug Metoprolol Pricing Read More »